Glucagon-like peptide 1 (GLP-1) metabolism was studied in halothane-anesthetized pigs
(n= 7) using processing-independent (PI) and COOH-terminal (C) radioimmunoassays (RIA) …

Intravenous glucagon-like peptide (GLP)-1 [7–36 amide] can normalize plasma glucose in
non-insulin-dependent diabetic (NIDDM) patients. Since this is no form for routine …

OBJECTIVE Glucagon-like peptide I (7–36)(GLP-I) amide, an endogenous incretin, has
been identified as a potential adjunct to the treatment of NIDDM and has been studied …

The pharmacokinetic properties of glucagon-like peptide-1 (7–36) amide and GLP-1 (7–37)
were compared. Four beagle dogs received on 4 separate occasions sc bolus doses of 50 …

Pharmacokinetics of several different preparations for subcutaneous administration of GLP-1
(7–36) amide (GLP-1) were studied. The difference between soluble GLP-1 at pH 4.0 and a …

As reviewed in Chap. 3, this volume, glucagon-like peptide-1 (GLP-1) is the designation
given to the sequence in proglucagon corresponding to residues Nos. 72–108 (Bell et al …

The incretins glucose-dependent insulinotropic polypeptide (GTP1-42) and truncated forms
of glucagon-like peptide-1 (GLP-I7-36 and GLP-I7. 37) are hormones released from the gut …

FIGURE 1. Schematic representation of the differential processing of proglucagon as it
occurs in the pancreatic islets and in the intestinal mucosa in man. The vertical lines in …